14-day Premium Trial Subscription Sign Up For FreeGet Free

Stock Market Week 20 - The Game Is On! Click to watch.

Bio-Techne Corp Stock Forecast

NASDAQ:TECH BUY SELL

$362.13 (-1.53%)

Volume: 198.158k

Closed: May 16, 2022

Hollow Logo Score: -3.024

Bio-Techne Corp Stock Forecast

BUY SELL NASDAQ:TECH
$362.13 (-1.53%)

Volume: 198.158k

Closed: May 16, 2022

Score Hollow Logo -3.024

Bio-Techne Corp Stock Forecast NASDAQ:TECH

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-05 38.07% Keybanc $600.00 $500.00 Maintains Overweight
2022-04-25 2.17% Wells Fargo $400.00 $370.00 Downgrades Equal-Weight Underweight
2022-02-02 58.78% SVB Leerink $530.00 $575.00 Maintains Outperform
2021-09-15 65.69% Keybanc $600.00 Upgrades Sector Weight Overweight
2021-06-29 32.55% SVB Leerink $450.00 $480.00 Maintains Outperform
2021-06-18 35.31% Argus Research $440.00 $490.00 Maintains Buy
2021-03-08 17.36% Stephens & Co. $380.00 $425.00 Upgrades Equal-Weight Overweight
2021-02-23 20.12% Stifel $435.00 Upgrades Hold Buy
2021-02-03 10.46% Citigroup $310.00 $400.00 Maintains Neutral
2021-02-03 21.5% Craig-Hallum $352.00 $440.00 Maintains Buy
2020-11-10 - Keybanc - Initiates Coverage On Sector Weight
2020-11-06 -11.63% SVB Leerink $285.00 $320.00 Maintains Outperform
2020-09-30 0.79% Atlantic Equities $365.00 Initiates Coverage On Overweight
2020-08-05 -21.3% SVB Leerink $265.00 $285.00 Maintains Outperform
2020-07-15 -24.61% Stephens & Co. $253.00 $273.00 Downgrades Overweight Equal-Weight
2020-06-18 -28.2% Citigroup $230.00 $260.00 Maintains Neutral
2020-05-27 -28.2% Stifel $245.00 $260.00 Downgrades Buy Hold
2020-05-14 -11.63% Benchmark $320.00 Initiates Coverage On Buy
2020-05-01 -30.14% Stephens & Co. $230.00 $253.00 Maintains Overweight
2020-05-01 -39.25% Wells Fargo $190.00 $220.00 Maintains Equal-Weight
2020-05-01 -32.34% Stifel $210.00 $245.00 Maintains Buy
2020-04-20 -40.63% Citigroup $175.00 $215.00 Maintains Neutral
2020-04-02 -42.01% Stifel $235.00 $210.00 Maintains Buy
2020-03-30 -47.53% Wells Fargo $225.00 $190.00 Maintains Equal-Weight
2020-03-20 -51.67% Citigroup $225.00 $175.00 Maintains Neutral
2020-02-05 -36.49% Baird $222.00 $230.00 Maintains Outperform
2020-02-05 -37.87% Citigroup $235.00 $225.00 Maintains Neutral
2020-01-08 -36.49% Wells Fargo $230.00 Initiates Coverage On Equal-Weight
2020-01-07 -35.11% Citigroup $235.00 Initiates Coverage On Neutral
2019-11-15 -35.11% Stifel $235.00 Initiates Coverage On Buy
2019-07-02 -25.44% Janney Montgomery Scott $200.00 $270.00 Upgrades Neutral Buy

TECH Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -9.95% during the next 3 months and, with a 90% probability hold a price between $302.84 and $386.42 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-18 $335.51 $381.92 $428.32
2022-05-19 $334.72 $381.13 $427.53
2022-05-20 $333.93 $380.34 $426.74
2022-05-23 $333.14 $379.55 $425.95
2022-05-24 $332.35 $378.76 $425.16
2022-05-25 $331.56 $377.97 $424.37
2022-05-26 $330.77 $377.18 $423.58
2022-05-27 $329.98 $376.39 $422.79
2022-05-31 $329.19 $375.60 $422.00
2022-06-01 $328.40 $374.81 $421.22
2022-06-02 $327.61 $374.02 $420.43
2022-06-03 $326.82 $373.23 $419.64
2022-06-06 $326.03 $372.44 $418.85
2022-06-07 $325.24 $371.65 $418.06
2022-06-08 $324.45 $370.86 $417.27
2022-06-09 $323.66 $370.07 $416.48
2022-06-10 $322.87 $369.28 $415.69
2022-06-13 $322.08 $368.49 $414.90
2022-06-14 $321.29 $367.70 $414.11
2022-06-15 $320.50 $366.91 $413.32
2022-06-16 $319.71 $366.12 $412.53
2022-06-17 $318.92 $365.33 $411.74
2022-06-21 $318.13 $364.54 $410.95
2022-06-22 $317.34 $363.75 $410.16
2022-06-23 $316.55 $362.96 $409.37
2022-06-24 $315.76 $362.17 $408.58
2022-06-27 $314.97 $361.38 $407.79
2022-06-28 $314.18 $360.59 $407.00
2022-06-29 $313.39 $359.80 $406.21
2022-06-30 $312.60 $359.01 $405.42

About Bio-Techne Corp

Bio-Techne Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells biotechnology reagents, instruments, and clinical diagnostic controls worldwide. The company operates through three segments: Biotechnology, Clinical Controls, and Protein Platforms. The Biotechnology segment provides proteins, such as cytokines, growth factors, and enzymes; polyclonal antibodies in goats, sheep, and rabbits, as well as monoclonal antibodies... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT